MicroRNA-1246 Mediates Drug Resistance and Metastasis in Breast Cancer by Targeting NFE2L3
MicroRNA (miR)-1246 is abnormally expressed and has pro-oncogenic functions in multiple types of cancer. In the present study, its functions in breast cancer and the underlying mechanisms were further elucidated. The clinical relevance of miR-1246 was analyzed and its expression in clinical specimen...
Guardado en:
Autores principales: | Yue-chu Dai, Yin Pan, Ming-ming Quan, Qi Chen, Yue Pan, Yan-yun Ruan, Jian-guo Sun |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/00d0608b71ad4e178d6f10bd52449bb2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Elevated expression of NFE2L3 promotes the development of gastric cancer through epithelial-mesenchymal transformation
por: Xiaodong Wang, et al.
Publicado: (2021) -
Suppression of miR-221 inhibits glioma cells proliferation and invasion via targeting SEMA3B
por: Cai,Guilan, et al.
Publicado: (2015) -
MicroRNA-107 is a novel tumor suppressor targeting POU3F2 in melanoma
por: Zhao,Guizhi, et al.
Publicado: (2020) -
Long non-coding RNA AFAP1-AS1 facilitates tumor growth and promotes metastasis in colorectal cancer
por: Han,Xu, et al.
Publicado: (2016) -
MiR-489-3p Reduced Pancreatic Cancer Proliferation and Metastasis By Targeting PKM2 and LDHA Involving Glycolysis
por: Dan Zhang, et al.
Publicado: (2021)